Dr. Sophia Frentzas
Claim this profileMonash Health
Area of expertise
Pancreatic Cancer
Sophia Frentzas has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:
Solid Tumors
Sophia Frentzas has run 3 trials for Solid Tumors. Some of their research focus areas include:
Clinical Trials Sophia Frentzas is currently running
AU-007
for Advanced Cancer
This is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007 in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination with a single loading dose of aldesleukin, or with both AU-007 and aldesleukin given every 2 weeks (Q2w). Once the recommended phase 2 dose (RP2D) of AU-007 plus aldesleukin was determined, (AU-007 Q2w plus a single loading dose of aldesleukin), AU-007 plus aldesleukin is also being administered with avelumab or nivolumab.
Recruiting
1 award
Phase 1 & 2
8 criteria
YL211
for Cancer
This is a multicenter, open-label, Phase 1 study. The study will enroll subjects with advanced solid tumors. It consists of three parts. Part 1 is dose-escalation part. In part 1, the safety and tolerability of YL211 in patients with selected advanced solid tumors will be evaluated and the MTD and RED will be determined. Part 2 is backfill enrollment part. We will further estimate the safety and efficacy of YL211 in patients with selected adcance tumor to select the RED(s) of YL211. Part 3 is dose-expansion part. In this part, we will further evaluate the safety and efficacy of YL211 at the MTD/RED(s) in patients with selected advanced solid tumors YL211 will be administered intravenously (IV) until criteria of treatment discontinuation are met.
Recruiting
1 award
Phase 1
2 criteria
More about Sophia Frentzas
Clinical Trial Related
4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Sophia Frentzas has experience with
- Aldesleukin
- AU-007
- AK104
- TAK-186
- YL211
- TAK-280
Breakdown of trials Sophia Frentzas has run
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sophia Frentzas specialize in?
Sophia Frentzas focuses on Pancreatic Cancer and Solid Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage III patients, or patients who are Stage IV.
Is Sophia Frentzas currently recruiting for clinical trials?
Yes, Sophia Frentzas is currently recruiting for 2 clinical trials in Clayton Victoria. If you're interested in participating, you should apply.
Are there any treatments that Sophia Frentzas has studied deeply?
Yes, Sophia Frentzas has studied treatments such as Aldesleukin, AU-007, AK104.
What is the best way to schedule an appointment with Sophia Frentzas?
Apply for one of the trials that Sophia Frentzas is conducting.
What is the office address of Sophia Frentzas?
The office of Sophia Frentzas is located at: Monash Health, Clayton, Victoria 3168 Australia. This is the address for their practice at the Monash Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.